在神经母细胞瘤中药理上准铁和
Ying Liu1, Joshua S Fleishman2, Hongquan Wang3
1Department of Pediatrics, The Fourth Affiliated Hospital of China Medical University, Shenyang, 100012, China. 20092406@cmu.edu.cn.
Molecular neurobiology
|September 27, 2024
概括
神经母细胞瘤的治疗耐药性可以通过向受调节的细胞死亡途径,如铁亡和亡来克服. 诱导这些细胞死亡类型为神经母细胞瘤治疗提供了一个有前途的新策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 神经母细胞瘤是一种严重的儿科癌症,经常出现治疗阻力和复发.
- 了解治疗耐药性的分子机制对于开发新疗法至关重要.
- 非亡调节细胞死亡 (RCD) 途径,包括铁和,与神经母细胞瘤耐药性有关.
研究的目的:
- 审查神经母细胞瘤病变发生过程中的铁和杯的机制.
- 探索用于神经母细胞瘤治疗的诱导铁或杯的治疗化合物.
- 突出针对新型神经母细胞瘤疗法的RCD向潜力.
主要方法:
- 关于神经母细胞瘤,治疗耐药性,铁亡和亡的研究的文献综述.
- 对癌症中调节细胞死亡的分子机制的分析.
- 检查新兴的治疗化合物,以铁和cuproptosis为目标.
主要成果:
- 损伤的铁质和质有助于神经母细胞瘤的进展和治疗耐药性.
- 针对ferroptosis和cuproptosis的特定化合物在临床前模型中显示出有希望的结果.
- 这些RCD途径的药理诱导可以克服治疗失败.
结论:
- 向铁质和质是一种针对神经母细胞瘤的新治疗策略.
- 诱导受调节的细胞死亡提供了一种可行的方法来对抗治疗耐药性.
- 需要进一步研究神经母细胞瘤中的铁和.
更多相关视频
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
5.5K
06:19Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
3.1K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K